VERV Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Verve Therapeutics Inc

Watchlist Manager

Watchlist

Price: 11.13 USD

Market Cap: $992.1m

	Verve Therapeutics Inc NASDAQ:VERV	US
	Brightstar Resources Ltd OTC:BTRAF	AU
	Avalonbay Communities Inc NYSE:AVB	US
	Tejas Networks Ltd NSE:TEJASNET	IN
	J Sainsbury PLC F:SUY	UK
	Hello Group Inc NASDAQ:MOMO	CN
	Orbital Corporation Ltd ASX:OEC	AU
	Tech Mahindra Ltd NSE:TECHM	IN
	Cogent Communications Holdings Inc NASDAQ:CCOI	US
O	Organon & Co F:7XP	US

Profitability Summary

Verve Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-350%

Negative 3Y Average Operating Margin

-1.628%

Operating Margin is Increasing

-3.838% > -350%

Negative Net Margin

-304%

Negative 3Y Average Net Margin

-1.457%

Net Margin is Increasing

-3.540% > -304%

Negative Free Cash Flow Margin

-247%

Negative 3Y Average Free Cash Flow Margin

-1.193%

Free Cash Flow Margin is Increasing

-3.182% > -247%

Negative ROE

-34%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-195%

ROIC is Increasing

-282% > -178%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.